ES2126775T3 - Procedimiento cromatografico de desplazamiento y producto de hemoglobina purificada. - Google Patents

Procedimiento cromatografico de desplazamiento y producto de hemoglobina purificada.

Info

Publication number
ES2126775T3
ES2126775T3 ES94926756T ES94926756T ES2126775T3 ES 2126775 T3 ES2126775 T3 ES 2126775T3 ES 94926756 T ES94926756 T ES 94926756T ES 94926756 T ES94926756 T ES 94926756T ES 2126775 T3 ES2126775 T3 ES 2126775T3
Authority
ES
Spain
Prior art keywords
hemoglobin
column
admixtures
stage
displacement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94926756T
Other languages
English (en)
Inventor
Diana Pliura
Diane Wiffen
Salman Ashraf
Anthony A Magnin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemosol Inc
Original Assignee
Hemosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002106612A external-priority patent/CA2106612C/en
Application filed by Hemosol Inc filed Critical Hemosol Inc
Application granted granted Critical
Publication of ES2126775T3 publication Critical patent/ES2126775T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422Displacement mode
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA HEMOGLOBINA ES PURIFICADA DE UNA SOLUCION EN BRUTO, PARA OBTENER UNA SOLUCION ACUOSA QUE CONTIENE AL MENOS EL 99% DE UNA ESPECIE DE HEMOGLOBINA PRESELECCIONADA, POR UN PROCESO DE CROMATOGRAFIA DE DESPLAZAMIENTO DE DOS ETAPAS. UNA DE LAS ETAPAS ES CONDUCIDA BAJO CONDICIONES DE CAMBIO DE ANION, Y LA OTRA BAJO CONDICIONES DE CAMBIO DE CATION. EN AMBAS ETAPAS, LA COLUMNA DE CAMBIO ES SOBRECARGADA PARA DESPLAZAR LAS ESPECIES DE HEMOGLOBINA DE ELLO CON CONTAMINANTES QUE TIENEN AFINIDAD MAS GRANDE POR LA COLUMNA, Y USANDO LA SOLUCION DE HEMOGLOBINA IMPURA COMO EL DESPLAZADOR. NORMALMENTE, EL CAMBIO DE ANION ES CONDUCIDO PRIMERO, CON LOS CONTAMINANTES MAS ACIDICOS QUE LA HEMOGLOBINA QUE DESPLAZA LA HEMOGLOBINA DE LA COLUMNA Y ELLOS MISMOS PERMANECEN UNIDOS A LA COLUMNA PARA LA SEPARACION. EL PROCESO DE CAMBIO DE CATION ES CONDUCIDO DESPUES, EN EL ELUYENTE DE LA PRIMERA COLUMNA, Y EN ESTA ETAPA, LOS CONTAMINANTES MAS BASICOS DESPLAZAN LA HEMOGLOBINA DESDE LA COLUMNA BAJO CONDICIONES DE SOBRECARGA, PARA PRODUCIR UNA SOLUCION DE HEMOGLOBINA SUSTANCIALMENTE PURA.
ES94926756T 1993-09-21 1994-09-20 Procedimiento cromatografico de desplazamiento y producto de hemoglobina purificada. Expired - Lifetime ES2126775T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002106612A CA2106612C (en) 1993-09-21 1993-09-21 Displacement chromatography process

Publications (1)

Publication Number Publication Date
ES2126775T3 true ES2126775T3 (es) 1999-04-01

Family

ID=4152343

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94926756T Expired - Lifetime ES2126775T3 (es) 1993-09-21 1994-09-20 Procedimiento cromatografico de desplazamiento y producto de hemoglobina purificada.

Country Status (9)

Country Link
JP (1) JP4057049B2 (es)
KR (1) KR100361894B1 (es)
AT (1) ATE175975T1 (es)
DE (1) DE69416103T2 (es)
DK (1) DK0668877T3 (es)
ES (1) ES2126775T3 (es)
HU (1) HU218159B (es)
RU (1) RU2145873C1 (es)
UA (1) UA35599C2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112006001012B4 (de) * 2005-04-22 2017-05-18 Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) Verfahren für eine auf Massenspektrometrie gerichtete Aufbereitung von Biopolymeren
CA2770235C (en) 2009-08-06 2021-06-29 Genentech, Inc. Method to improve virus removal in protein purification
EP2640483A1 (en) * 2010-11-15 2013-09-25 Biogen Idec Inc. Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
JP6605202B2 (ja) 2011-12-22 2019-11-13 ジェネンテック, インコーポレイテッド イオン交換膜クロマトグラフィー
SG11201508968XA (en) * 2013-05-06 2015-11-27 Sanofi Sa Continuous multistep process for purifying antibodies
TW202128264A (zh) * 2019-09-25 2021-08-01 瑞士商赫孚孟拉羅股份公司 使用經預測之溶離緩衝鹽濃度的陽離子層析法
CN114712894B (zh) * 2022-04-08 2024-04-30 无锡博慧斯生物医药科技有限公司 一种糖化血红蛋白层析柱的活化液、活化方法和应用

Also Published As

Publication number Publication date
DE69416103D1 (de) 1999-03-04
HU218159B (hu) 2000-06-28
HUT72924A (en) 1996-06-28
JPH08503714A (ja) 1996-04-23
ATE175975T1 (de) 1999-02-15
JP4057049B2 (ja) 2008-03-05
DK0668877T3 (da) 1999-09-13
RU95112503A (ru) 1996-12-20
DE69416103T2 (de) 1999-08-05
RU2145873C1 (ru) 2000-02-27
UA35599C2 (uk) 2001-04-16
HU9501479D0 (en) 1995-07-28
KR100361894B1 (ko) 2003-05-12

Similar Documents

Publication Publication Date Title
ES2139794T3 (es) Purificacion de inhibidor de proteinasa alfa-1 usando nuevas condiciones de separacion cromatografica.
ATE338059T1 (de) Reinigung von echinocandin cyclopeptiden
SE9603068D0 (sv) Process for purifying a protein
ES2126775T3 (es) Procedimiento cromatografico de desplazamiento y producto de hemoglobina purificada.
ES2117703T3 (es) Preparacion de factor viii.
DE69700134D1 (de) Gereinigtes naturglasprodukt
KR880001699A (ko) 연골-유도된 백혈구 엘라스타제-억제제
EP0282363A3 (en) Method for preparation of a concentrate of alpha-1-antitrypsin from a human plasma fraction, and its use as a pharmaceutical
IL87543A0 (en) Interleukin 1 inhibitors,methods for the purification thereof and pharmaceutical compositions containing the same
EP0373540A3 (en) Method for purifying fibroblast growth factor protein
ATE381577T1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
FR2672895B1 (fr) Procede de purification d'une proteine fortement glycosylee.
Hansson et al. Adsorption and desorption of proteins in metal chelate affinity chromatography: purification of albumin
WO1999009004A3 (en) Process for preparing and/or purifying amido acid phenyl ester sulfonates
DE69411492D1 (de) Verfahren zur Reinigung von mittleren Olefinen
BG102663A (en) Method for the purification of thrombino-like proteases from snake poison
GR3025944T3 (en) Purification of factor xiii.
IT1264418B1 (it) Procedimento per l'ottenimento di glicerofosfolipidi
JPS557006A (en) Purification of urokinase
ES2074935A1 (es) Proteina ebulina 1 de la planta sambucus ebulus l., procedimiento para su obtencion y su utilizacion.
KR970070017A (ko) 재조합 인 과립구 콜로니 자극인자(rhG-CSF)의 정제방법
ES2072184A1 (es) Proteina petroglaucina i de la planta petrocoptis glaucifolia (lag.)boiss, procedimiento para su obtencion y su utilizacion.
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method
RU93054542A (ru) Способ определения гликированного гемоглобина в крови
DE10045935A1 (de) Stoff aus dem Gift der Schlage Bitis gabonica rhinoceros

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 668877

Country of ref document: ES